Walsh Dennis Leo 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Walsh Dennis Leo
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-17$15.30/sh+3,269$50,000→ 3,269 totalExercise: $21.27Exp: 2033-01-16→ Common Stock (3,269 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2023 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.